BenzingaOctober 9, 2026 at 11:11 AM NY18 Days Ago
JP Morgan Initiates Coverage On Definium Therapeutics with Overweight Rating, Announces Price Target of $84
JP Morgan initiates coverage on Definium Therapeutics (NASDAQ:DFTX) with a Overweight rating and announces Price Target of $84.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
